Bernard Birkett - 18 Feb 2025 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Role
Sr VP, Chief Financial Officer
Signature
/s/ Louis Lalli, as an agent for Bernard Birkett
Issuer symbol
WST
Transactions as of
18 Feb 2025
Net transactions value
+$133,133
Form type
4
Filing time
20 Feb 2025, 21:44:56 UTC
Previous filing
22 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WST Common Stock Options Exercise $164,443 +779 +11% $211.00 7,669 18 Feb 2025 Direct
transaction WST Common Stock Tax liability $50,168 -238 -3.1% $211.00 7,431 18 Feb 2025 Direct
transaction WST Common Stock Options Exercise $26,370 +125 +1.7% $211.00 7,556 18 Feb 2025 Direct
transaction WST Common Stock Tax liability $7,513 -36 -0.47% $211.00 7,520 18 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WST Stock Option (Right to Buy) Award $0 +4,020 $0.000000 4,020 18 Feb 2025 Common Stock 4,020 $211.00 Direct F1
transaction WST Rst. Stock Unit Award $0 +1,740 $0.000000 1,740 18 Feb 2025 Common Stock 1,740 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This award vests in four equal installments beginning on February 18, 2026.